Cramer Picks - the Pumps and Pullbacks

[madrose1]

Sell BRLC. Movado (MOV): take some profits off the table. BigBand Networks (BBND): buy on weakness. Sourcefire (FIRE): take some profits. Then, Cramer evaluated Volcano (VOLC) and spoke briefly with CEO Scott Huennekens. Cramer: This Volacano story is one I really like; VOLC is a Buy. In the Sudden Death Round, Cramer had the following recommendations - Buy: Brush (BW), Allegheny Tech (ATI), and FactSet (FDS). Sell: LHC Group (LHCG) and Frontline (FRO).

[madrose1]

was bearish on: Yum Brands (YUM), Stride Rite (SRR), and Nvidia (NVDA). In the Sell Block Round, Cramer had the following recommendations - Sell: Syntax-Brillian (BRLC) - Cramer said the CEO did a side deal to buy shares from a big shareholders at a discount. Cramer:

[madrose1]

was bullish on: Genentech (DNA), Gilead (GILD), Celgene (CELG), Genzyme (GENZ), Time Warner (TWC), Verizon (VZ), Sears Holding (SHLD), Transocean (RIG), Global Santa Fe (GSF), Devon Energy (DVN), Cheesecake Factory (CAKE), Chipotle (CMG), Ameritrade (AMTD), Quest (Q), Kinder Morgan (KMP), and GMarket (GMKT): but sell GMKT on a rise to $20.

[madrose1]

likes: Company #4: Ralph Lauren (RL), which is undertaking brand elevation. And Company #5: Saks (SKS), which has hired a merchandizing whiz. In the Lightning Round, Cramer

[madrose1]

Buy Linhas Areas (GOL) $31 , a Brazilian airline. Cramer: I'm generally not behind airlines, except CAL. But Brazil is displaying a pro-growth strategic, which helps make GOL attractive. GOL is sort of a Brazilian Jet Blue (JBLU) without JBLU's problems. Also, a recent GOL acquisition positioned the company as the cheapest airline stock in the world, Cramer asserted. Cramer: I see GOL quickly heading to $40, hence don't wait for a pull-pack to Buy GOL. Next, Cramer continued with his "Benefit of the Doubt" list. Cramer

[madrose1]

Jim Cramer's "Mad Money"
During Monday's "Mad Money" show, Cramer evaluated Biosite (BSTE), a Feb. 23 Buy recommendation of his, which recently received a takeover bid. Cramer: Up handsomely on the BEC's $85 per share buy-out offer, now it's time to Sell BSTE. Cramer: Now I like Cephid (CPHD.) Sell BSTE, and roll some profits into CPHD. But please, wait 3 days before buying CPHD, buy market hours, with limit orders only, but this is a great stock. CPHD will benefit from the pro-diagnostic sentiment in the new Democratic Party-led U.S. Congress. And I think CPHD will be a great acquisition candidate. Next, Cramer said his paranoia and cynicism has paid off, but that trust can sometimes make you money. Cramer: Further, some CEOs deserve the benefit of the doubt, hence my new "Benefit of the Doubt" CEO list. At the top of the list: VF Corp (VFC) CEO’s Mackey McDonald - if/when VFC misses its next monthly same store sales estimate, you can give VFC the benefit of the doubt. Cramer: For proof, look at VFC's chart. In the Lightning Round, Cramer was bullish on: Transocean (RIG), Bank of America (BAC), Thermo Fisher (TMO), Western Union (WU), Best Buy (BBY), Lundin (LMC), BigBand (BBND), and Cisco (CSCO). In the Lightning Round, Cramer was bearish on: Helix (HLX), and Northern Orion (NTO). PDLI BioPharma (PDLI), an underperforming biopharma. Cramer: This is classic management underperformance company. Enter Third Point LLC, now with a +5% stake and a seat on the board: they are experienced activists, who believe PDLI's stock should be in the high $30s, not around $20. Cramer: Piggyback on Third Point's work and Buy PDLI. In the Sudden Death Round, Cramer had the following recommendations - Buy: Western Refining (WNR), Valero Energy (VLO), and Energy Metals (EMU). Sell: No stocks mentioned.

[madrose1]

was bearish on Boston Scientific (BSX), Baidu.com (BIDU), Pozen (POZN), Nokia (NOK) and Motorola (MOT).

[madrose1]

was bullish on Cleveland-Cliffs (CLF), Vodafone (VOD), Gilead Sciences (GILD), Celgene (CELG), Genzyme (GENZ), Infosys Technologies (INFY), Accenture (ACN), Six Flags (SIX), Sun Microsystems (SUNW), Indevus Pharmaceuticals (IDEV), Apple and Amgen (AMGN), and

[madrose1]

suggested buying First Solar & FCX (FSLR ) as a solar play. Cramer then recommended Freeport-McMoRan (FCX), which he said could hit $100. In the "Lightning Round," Cramer

[madrose1]

also likes Apple (AAPL) and Hewlett-Packard (HPQ). Cramer expects strong earnings from Phillips-Van Heusen (PVH), CarMax (KMX), Accenture (ACN) and DSW (DSW) this week, but his stock pick of the week on earnings is Movado (MOV). Cramer also

[madrose1]

buying Brocade (BRCD) before the company's analyst meeting on Thursday because he expects Brocade to raise its estimates at the meeting. He also said Cisco (CSCO) could buy Brocade. He said he

[madrose1]

recommends Haynes International (HAYN). On Tuesday, the co brought a secondary offering to the market in an effort to improve its balance sheet. Next, he suggests Novo Nordisk (NVO) because of its diabetes business and the fact that it is not U.S.-based. Not only does Novo Nordisk have 50% of the global market in diabetes care, the Denmark-based drug co is blowing away its competitors, he said. Novo Nordisk has "some of the best" insulin analogues and a patent protection for them. Plus, Novo Nordisk is already selling human insulin at low prices, which keeps it clear from generic-drug competitors, Cramer said.

[madrose1]

Cramer was bullish on KB Home (KBH), Citigroup (C), Walter Industries (WLT), Harley-Davidson (HOG), Lundin Mining (LMC), First Solar (FSLR), Exxon Mobil (XOM), XTO Energy (XTO) and Transocean (RIG).

[pantera]

I'm certainly not in love with the stock currently but I love the company. I am underwater with it but will continue to add.....just call me stubborn. It might just see $56 or for that matter, $52.

[madrose1]

AMGN $59.30...what a pounding this has taken & Cramer still loves the stock

watching here & the $56-$57.50 area , just hitting the OS
on the weekly there's the dtop @ $77<g

[madrose1]

The defaulted-loans business is "fabulous" and "much better than the competitive nature of subprime," Jim Cramer said on Wall Street Confidential Thursday. Jim went back in time and told us about the time he was working at Goldman Sachs Group Inc (GS) and American Southwest Mortgage Group was being defaulted. During that period $1 billion of paper at American Southwest mortgages were worthless and Jim couldn't believe the number of buyers he saw. Now The Bear Stearns Companies Inc (BSC) is doing the same thing by selling mortgage distressed debt. Jim stated that the brokers are now making big money by doing this now. Greenberg asked Jim to rank the top brokers in the midst of this subprime crisis. Jim gave Goldman Sachs Group Inc (GS) which he owns for his trust the #1 seed. Jim thinks that GS is going to $250 and he would be an aggressive buyer. Jim gave the #2 seed to The Bear Stearns Companies Inc (BSC) because this company has been more proactive than Lehman on the mortgage issue. Jim made bearish comments on Merrill Lynch & Co. Inc (MER) calling this stock a short. Jim doesn't like that MER is early into the mortgage business and they haven't been proactive. Jim attributed the fat bounce in Accredited Home Lenders Holding Co (LEND) and IndyMac Bancorp Inc (NDE) to massive short covering. Jim thinks that the dirty dozen list he mentioned yesterday caused companies to take action and show they don't belong on that list. "I never said they did belong on the list," he said. "It is a list of companies that are being targeted, not of companies that I believe should go down." Jim made the surprising comment that he would be more interested in being long stocks on the dirty dozen then short.
Watch the VIDEO HERE..

[madrose1]

buy Goldman Sachs Group Inc (GS) aggressively on Monday morning. Jim owns GS for his trust and Cramer thinks that Goldman will start a big stock buyback on Tuesday.

[madrose1]

told investors to get in AAR CORP (AIR) before it reports earnings on Wednesday, buy General Mills Inc (GIS) before it reports on Thursday and

[madrose1]

bullish comments on National CineMedia Inc (NCMI) telling investors to look to make a move on this stock for next week. Jim likes this stock for a play on movie theaters. He sees the ads in cinemas as a fast growing sector. Jim talked about a Washington Post report that a $20 billion government phone contract is in the works. Jim thinks the players here are Verizon Communications Inc (VZ), AT&T Inc (T), Sprint Nextel Corporation (S) and Qwest Communications International Inc (Q). Jim thinks the front runner is Qwest to win the deal.

[madrose1]

NSTK $10 ...Next Biotech Stock To Move Nastech Pharmaceutical Company Inc

Jim went back in time tonight and discussed the stock Regeneron Pharmaceuticals Inc (REGN). In the past Jim had the CEO of Regeneron on the show when the stock was trading at $5. The stock took off and hit $24 then pulled back to $18. The stock did that, Cramer said, even though it doesn't have a "concrete" product and its revenue is in a decline. Jim knew this stock would explode higher because biotech stocks are insane. Jim went on to explain that in the biotech sector the worst stock can turn into the best on nothing but hope of future value. Jim thinks the next Regeneron will be Nastech Pharmaceutical Company Inc (NSTK). People in this business moan when Nastech Pharmaceutical's name is mentioned, Cramer said. It overpromises, underdelivers and is "a comedy of errors." Plus, it doesn't have a single important drug that's ready to come to the market, he said. "It's a joke, just like the last joke I told." Jim thinks this stock will trade higher because it has money from raising cash recently and it has the hope factor for the company's compounds. The company has finally figured this out, and now that it has the "religion of silence," it should be ready to move, he said. Jim is also bullish on NSTK's obesity drug, insulin delivery drug, and for a play on autism. Jim wants investors to look over this company this weekend before getting in and he also wants investors to use limit orders when buying.

[madrose1]

In the Sudden Death Round recommendations Buy: Sirius Satellite (SIRI), Reliant Resources (RRI), and Acme Packet (APKT).

[madrose1]

Sell most tech stocks, including: ORCL, MSFT, IBM, INTC, AMD. Cramer Likes: EBAY, YHOO, AAPL, QCOM, AKAM, CSCO. Next, Cramer evaluated Medco Health (MHS) and spoke briefly with CEO David Smith. Cramer: What can I say? Real visibility and fabulous growth - this is the definition of the type of company you need to buy in this market.

[madrose1]

was bearish on: Gateway (GTW) Sanofi-Aventis (SNY), and Medimmune (MEDI).

[madrose1]

bullish on: ABB (ABB), Riverbed (RVBD), Hewlett-Packard (HPQ), Allegheny Tech (ATI), Gilead (GILD), Genzyme (GENZ), Celegne (CELG), Investors Bancorp (ISBC), Dean Foods (DF), UnitedHealth (UNH), Cigna (CI), Level 3 (LVLT), and Qwest (Q).

[madrose1]

evaluated the current market, and expanded on buy-backs. Cramer: On a down day, when a company steps in to buy its own stock, that's a positive sign for that company. Also, when I say, "There's always a bull market somewhere," I mean it. Right now the single biggest bullish market is in non-pharm health care. Cramer likes: Cigna (CI). CI is a managed care/life insurance/accident insurance hybrid. CI has been growing at 12% and sells for 13x earnings: too cheap, and CI knows it, because they're buying back their stock. Cramer: Get with Cigna's management and Buy CI. Next, Cramer discussed Volcano Corporation (VOLC). Caution: Use limited orders with VOLC, and I prefer that you buy it next week. They make ivus catheters, a device that enables physicians to see inside an artery. More ivus catheters are needed, given the drug-coated stent controversy, which means more business for VOLC. And VOLC has partnered with Johnson & Johnson (JNJ).

[madrose1]

BigBand Networks (BBND) announces pricing of initial public offering for 3/15

Co announced an initial public offering of 10.7 shares of its common stock at a price of $13.00 per share (before underwriting discounts and commissions). Of those shares, BigBand Networks will sell 7,500,000 shares and selling stockholders will sell 3,200,000 shares. Several of its stockholders have granted the underwriters the right to purchase an additional 1,605,000 shares of common stock to cover over-allotments. BigBand's common stock will be listed on the Nasdaq Global Market under the symbol "BBND" and will begin trading on March 15, 2007.

BigBand Networks
http://www.bigbandnet.com/

Despite the recent market jitters and some mixed trading among last week’s new issues, BigBand Networks has all the key ingredients of a hot technology IPO. The venture-backed, Redwood City, CA based company sells broadband networking gear that enables cable and telecom companies to efficiently deliver bandwidth-hungry video services. The offering consists of 10.7 million shares (3.2 million from insiders) at a price of $10-$12 per share, giving BigBand a proposed market capitalization of $774 million. Lead underwriters Morgan Stanley and Merrill Lynch expect to price the deal Tuesday evening.

Company Background

Founded in 1998 by a pair of accomplished engineers from Israeli digital video technology specialist Optibase, BigBand has developed a highly intelligent processing platform that is purpose-built for the efficient delivery of video services such as HDTV and video-on-demand. While these services are among the most attractive offerings from broadband and cable operators, they are also the most demanding because of their massive bandwidth and processing requirements. BigBand has addressed this issue by combining rich media processing and routing capabilities with intelligent software designed to optimize the delivery of video content. The company has produced a portfolio of innovative processing technologies, including a recently introduced application called “Switched Broadcast” (BigBand claims to be the industry’s first-mover), which enables cable and telecom operators to transmit only those video channels in use, thereby freeing up substantial bandwidth for other applications.

Selling to big customers with big pockets

BigBand counts nine of the top 10 cable operators the US as its customers, including Comcast, Cox, Time Warner Cable and Cablevision, all of which are spending aggressively to rollout enhanced video services as part of their “triple-play” of services. While the company has historically focused on the major domestic cable operators, it has recently begun selling to telecom carriers as well, including winning a major deployment at Verizon. Specifically, BigBand’s products are being used to support Verizon’s new FiOS TV offering, which is an integral part of Verizon’s huge $18 billion fiber-to-the-home initiative. In total, the company has shipped products to over 100 broadband carriers globally and its platform is currently supporting over 50 million subscribers.

The key takeaway for investors here is not just that BigBand’s products are being sold to many of the top US carriers, but these customers (and the industry at large) are committing large -- and increasing - amounts of capital to beefing up their networks. In 2006, estimated total spending on cable/TV infrastructure equipment was $2 billion. That figure is expected to reach $6.4 billion in 2009 reflecting a CAGR of 33%.

Ramping revenues and earnings

BigBand has put up impressive numbers over the last few years, driven by increasing deployments at its key cable customers and new customer wins, mostly notably Verizon which as quickly become the company’s largest customer. Over the last three years, revenue has surged from $36 million to $98 million to $177 million. Operating leverage has also kicked-in a big way with operating cash flow reaching $21 million in 2006 compared to a loss of -$16 million in 2005. Results have looked even more impressive on a quarterly basis, with revenue ramping considerably over the last four quarters. For its most recent 4Q06, BigBand generated $63 million in revenue, up 46% from the September quarter. Operating cash flow soared to $14 million, up 216% sequentially.

Customer concentration is a double-edged sword

While BigBand’s success in signing up some of the biggest broadband/cable carriers positions it well to benefit from continued strong spending trends, the company’s sales are concentrated heavily among just a handful of customers (top five account for 80-90% of sales), which sets the stage for potentially lumpy results should any one of its key customers shift its deployment schedules. Verizon accounted for almost $56 million in revenue in 2006, of which $26 million came in its 4Q0Q.

Competition Looms

One of the bigger long-term concerns here relates to BigBand’s ability to maintain its technology lead over several major networking competitors with substantial resources at their disposal. In the cable/video networking arena, BigBand squares off against the likes of Cisco and Motorola, both of which have been enhancing their products through niche acquisitions. Other pure-play video networking vendors that could pose a more significant competitive threat down the road include Harmonic, Tandberg TV (being acquired by Ericsson) and Terayon Communications (rumored to be on the selling block).

Management

We are impressed with management’s execution to date, specifically its ability to develop a compelling product that is being broadly deployed by the US cable market in addition to getting a huge endorsement from one of the most established telcos (Verizon). BigBand’s co-founders bring strong technical backgrounds to the table, and more importantly, the company has added several experienced networking and technology executives to its ranks, including the recent hiring of Juniper Networks’ former VP of Worldwide Sales. On the flip side, the selling by insiders on the deal is a turnoff and the company has issued a huge number of cheap options, which will be dilutive to new shareholders.

Valuation

Based on the company’s current growth trajectory, the valuation appears attractive relative to other high-growth networking companies as well as recent buyout multiples in the sector, including the pending acquisition of Tandberg TV for $1.4 billion (roughly 4x 2007 sales) and the recent acquisition of Redback Networks for $1.9 billion (roughly 6x 2007 sales) - both by Ericsson. While both of these firms are larger and more established than BigBand, clearly these deals provide positive benchmarks for BigBand, which looks to be coming to market at less than 3x forward sales (based on our assumption of roughly 30% growth in 2007).

A hot deal

BigBand has many of the key ingredients of a hot technology IPO, including (but not limited to):



Rapid growth and ramping profitability
Proven deployments at 6 of the top 10 service providers in the US
Technology leadership
Large market opportunity with signs of accelerating growth
Reputable venture backers
While the company’s huge customer concentration and expected competition represent notable risks, BigBand’s strong customer endorsement to date, attractive growth prospects and reasonable valuation all point to a big-time debut.

[CoolHandLucas]

Complacency still abounds and it will be punished. This market is in more trouble than people want to admit. The bears aren't going to be done on Friday, they have smelled blood in this market again, and this second time in less than a month with the $VIX spiking it will get much worse before it gets better this time. Buying GS or any other investment broker on Friday is a mistake in my humble opinion. If you really want to be long GS, wait until it goes down to the 200 day moving average.

I think GS dips to 170 this year.

[orion.colorado]

RE: OIH thanks again for bringing this one to my attention last year. Waded in with ss around the revisit (the previous visit was ss'ed as well) to the OB 141 mark today.

Couldn't post...on baby duty since our nanny was sick.

Cheers,

[madrose1]

Then, Cramer evaluated Dow Chemical (DOW) and Alcoa (AA), two potential takeover targets. Cramer: DOW has solid fundamentals, adequate yield, and has chemical sector pricing power. AA: aluminum demand should catch up with supply, improving AA's pricing power, and AA could be worth $49 if broken up. Next, Cramer evaluated Comcast (CMCSA) and spoke briefly with CEO Brian Roberts. Cramer: I think Roberts is money in the bank - CMCSA is a Buy.

[madrose1]

was bullish on: Apple (AAPL), Yumana (AUY), Lockheed Martin (LMT), General Dynamics (GD), Genentech (DNA), Gilead (GILD), Celgene (CELG), Genzyme (GENZ), Microsoft (MSFT), Diamond Offshore (DO), Transocean (RIG), Global SantaFe (GSF), and Garmin (GRMN): buy on a pull-back to $50.

[madrose1]

During Tuesday's "Mad Money," Cramer evaluated the market's second, broad-based sell-off in 10 sessions Tuesday, a 242-point decline for the DJIA. Cramer: What drove it? Obviously the sub-prime lenders who have made bad loans / risky loans built on the thesis that they could flip houses like stocks and make high-risk loans to the poor/working poor. Why did the mortgage weakness spread so quickly to the broader market? Cramer: Because traders are selling everything in the S&P 500: they're not making a distinction. Cramer: What to do now? Identify those stocks that were marked down for the wrong reasons. Clearly, the entire market went down out of investor fear, manifested by selling the S&P 500. Who will do well if housing collapses? Food, drug, and utility stocks. Cramer: But due to options expiration this week, sit tight through Friday: sit on your hands. Then, next week consider buying: SWY, VZ, T, CL, KMB, or RIG. Next, Cramer outlined how to play defense: identify companies that do well no matter how bad the economy gets. Cramer likes: Altria (MO). Cramer likes MO-WI (MO's when issued shares), which is pure play Phillip Morris, sans Kraft, which is just what Cramer wants in MO: just the tobacco play. Cramer: If you want a food stock, buy General Mills (GIS) or Kellogg (K).

[pantera]

Mars,

You might be able to get RIG @ $70? Prefer DO currently with their current contract visability. Why own GSF when RIG and DO are the diamonds in the drilling patch?

[madrose1]

Cramer was right on GS short & buy back before friday after th dust clears ...and he did say not to buy RIG there ($77's) but wait the same .

POO really took a dive this am , as did everything else ...it was needed correction , the oil trades looked a little OB & the d-top hit again on the OIH $141's...

nice to be able to get RIG $73's ...

[pantera]

Mars,

Although RIG is my single largest holding by a long shot.....Cramer has got to be crazy to leave off DO from his list!

[kumqwatt]

Appreciate it!!!

[madrose1]

evaluated Hansen Medical (HNSN $17 ). Cramer: Be careful with small-cap HNSN. Buy day hours, with tight limit orders, but wait a couple days to buy it. HNSN could be the next Intuitive Surgical (ISRG). Cramer: HNSN is currently losing money, but I remain impressed by its robotic catheter, yet to approved, which helps doctors use a catheter more effectively. Caution: Don't feel compelled to buy HNSN soon, as Cramer sees H2 stock gains.

[madrose1]

was bearish on: Heelys (HLYS) and Quiksilver (ZQK). Next,

[madrose1]

was bullish on: Ford (F) buy F's convertible bond only, not the common stock; Denny's (DENN), Blockbuster (BBI), CVRD (RIO), NYSE Group (NYX): which Cramer believes is the most undervalued stock on the NYSE, no pun intended; EBay (EBAY), Yahoo (YHOO), and BEA Systems (BEAS).

[madrose1]

Cramer evaluated oil / oil service stocks. Cramer: likes: Schlumberger (SLB), National Oilwell Varco (NOV), GlobalSantaFe (GSF). Cramer really likes: Halliburton (HAL) and Transocean (RIG). Cramer: No matter what HAL does, it gets no respect from Wall Street. The new Dubai headquarters is not relevant. I think HAL is likely to jump up soon, and do not tender your HAL shares for its KBR spin-off.

On Transocean (RIG), Cramer said big oil needs to drill and drill deep, RIG is the best driller around, and its primary products have significant pricing power. However, wait until Friday March 16 to buy RIG, as it is options expirations week, and RIG undoubtedly will be affected, probably dropping to $75 on Friday. [Among the oil production companies, the only name Cramer likes now is BP (BP).]

[antman]

-as well as 'nuclear hardened stocks' maybe Cramer should be recommending uranium stocks looking for nuclear fuel!

Look at LAM.TSE for example-

WRI.V is a uranium exploration junior I am long-
They have a big package of land with a lot of targets in the Quebec Labrador trough-

Due your own due dilgience....

[madrose1]

- Buy: GS, UNP. Sell: JEF, FRPT.

[madrose1]

Buy: SDXC, EQIX, AVAV, OPXT. Next Cramer evaluated AT&T (T) and spoke briefly with CFO Rich Lindner. Cramer: I tend not to recommend long-term stocks, but if you have a child, and you're looking for a long-term stock, that you put away and it builds value, this is it.

[madrose1]

was bearish on: RF Micro-Devices (RFMD) and Bristol-Myers (BMY). In the Sell Block Round, Cramer had the following recommendations: Sell: FIG, MPEL, IPGP. On Melco, Cramer said "I simply got it wrong with MPEL."

[madrose1]

was bullish on: Sakes (SKS), Sprint Nextel (S): S is a Buy particularly under $20; Halliburton (HAL), Transocean (RIG), Logitech (LOGI), Dean Foods (DF), Genzyme (GENZ), Gilead (GILD), Celegene (CELG), Walter Industries (WLT), Baxter (BAX), Continental (CAL), Mastercard (MA), Emerson Electric (EMR), Global Santa Fe (GSF), and Vail Resorts (MTN).

[madrose1]

re-visited the sub-prime sector issue. Cramer: Until the Fed lowers interest rates to help stimulate mortgage lending to moderate-income applicants/candidates, the sub-prime sector will be squeezed / experience doldrums.

Cramer then outlined the best way to play the sub-prime crunch: Buy Cash America (CSH) and Advance America Cash (AEA). Next, Cramer evaluated Chemed (CHE), one of Cramer's "stocks that reported great earnings but was taken down with the market during the recent 400-pt sell-off." CHE operates Roto-Rooter and hospices. Cramer: CHE is exceeding expectations, it pulled-back some during the sell-off, but I think it has a shining path to $50. It's best to Buy CHE before it regains its momentum.

[madrose1]

was bullish on: MGM Mirage (MGM), Blockbuster (BBI), Infosys (INFY), Interactive (IACI), Texas Roadhouse (TXRH), Sonic (SONC), Great Plains Energy (GXP), Apple (AAPL), Google (GOOG) buy below $440; Yahoo (YHOO), EBAY (EBAY), and Bank of America (BAC).

In the Lightning Round, Cramer was bearish on: Shuttlerfly (SFLY).

Next, Cramer evaluated VeriFone (PAY) and spoke briefly with CEO Douglas Bergeron. Cramer: We've identified some pretty good stocks on this show, this is one: this stock has pulled back, so get in on PAY now. In the Sudden Death Round, Cramer had the following recommendations - Buy: Cognizant (CTSH) and Dean Foods (DF). Sell: No stocks mentioned.

[madrose1]

Next, Cramer evaluated First Solar (FSLR). Cramer: FSLR is great to buy now, as it is one of the companies that reported a great quarter, but sold-off, unjustifiably, with the pack during the Dow's 400-pt drop. Cramer: I see brighter days ahead for FSLR, as the company doesn't use silicon, but uses other elements, to make panels. Buy FSLR. In the Lightning Round, Cramer

[madrose1]

Cramer likes: pharmacy benefit managers and tire companies. Cramer's picks: Medco Health (MHS) and Goodyear Tire (GT). MHS's ability to batch-together drugs and save money is practically unrivaled. He also likes Express Scripts (ESRX). Meanwhile, Goodyear (GT) has slashed worker benefits and pension requirements, which will really help GT's bottom line. For both MHS and GT, buy some now, then hope for a pull-back to buy more.

[madrose1]

said the tactic now is to find "nuclear hardened stocks" - stocks that have survived the 400-pt sell-off. Where to look? Cramer: The new-high list.

[kumqwatt]

I missed your updates last couple of days--please continue.
Thank you